IN8bio, Inc. (INAB)
NASDAQ: INAB · IEX Real-Time Price · USD
5.85
-0.16 (-2.66%)
After-hours:Oct 15, 2021 6:58 PM EDT
6.01
0.00 (0.00%)
At close: Oct 15, 4:00 PM
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 |
|---|---|---|
| Selling, General & Admin | 3.18 | 2.71 |
| Research & Development | 5.38 | 2.36 |
| Other Operating Expenses | 0 | 0.07 |
| Operating Expenses | 8.56 | 5.13 |
| Operating Income | -8.56 | -5.13 |
| Other Expense / Income | 1.78 | 0.78 |
| Pretax Income | -10.34 | -5.91 |
| Net Income | -10.34 | -5.91 |
| Net Income Common | -10.34 | -5.91 |
| Shares Outstanding (Basic) | 3 | 3 |
| Shares Outstanding (Diluted) | 3 | 3 |
| Shares Change | 7.24% | - |
| EPS (Basic) | -3.02 | -1.85 |
| EPS (Diluted) | -3.02 | -1.85 |
| Free Cash Flow Per Share | -2.09 | -1.39 |
| EBITDA | -10.25 | -5.82 |
| EBIT | -10.34 | -5.91 |